Announcement • May 20
Yangmei Chemical Co.,Ltd, Annual General Meeting, Jun 12, 2026 Yangmei Chemical Co.,Ltd, Annual General Meeting, Jun 12, 2026, at 09:30 China Standard Time. Location: No. 72, Shuangta West Street, Yingze District, Taiyuan, Shanxi China New Risk • Apr 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). Earnings have declined by 60% per year over the past 5 years. Reported Earnings • Apr 20
Full year 2025 earnings released: CN¥0.35 loss per share (vs CN¥0.29 loss in FY 2024) Full year 2025 results: CN¥0.35 loss per share (further deteriorated from CN¥0.29 loss in FY 2024). Revenue: CN¥9.85b (down 9.6% from FY 2024). Net loss: CN¥825.3m (loss widened 21% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Announcement • Mar 30
Yangmei Chemical Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026 Yangmei Chemical Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026 New Risk • Mar 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 49% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change). New Risk • Feb 09
New major risk - Revenue and earnings growth Earnings have declined by 49% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Announcement • Dec 26
Yangmei Chemical Co.,Ltd to Report Fiscal Year 2025 Results on Apr 18, 2026 Yangmei Chemical Co.,Ltd announced that they will report fiscal year 2025 results on Apr 18, 2026 Announcement • Sep 30
Yangmei Chemical Co.,Ltd to Report Q3, 2025 Results on Oct 31, 2025 Yangmei Chemical Co.,Ltd announced that they will report Q3, 2025 results on Oct 31, 2025 New Risk • Sep 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Announcement • Jun 30
Yangmei Chemical Co.,Ltd to Report First Half, 2025 Results on Aug 30, 2025 Yangmei Chemical Co.,Ltd announced that they will report first half, 2025 results on Aug 30, 2025 Announcement • May 30
Yangmei Chemical Co.,Ltd, Annual General Meeting, Jun 24, 2025 Yangmei Chemical Co.,Ltd, Annual General Meeting, Jun 24, 2025, at 09:30 China Standard Time. Reported Earnings • Apr 19
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: CN¥0.29 loss per share (improved from CN¥0.39 loss in FY 2023). Revenue: CN¥10.9b (down 9.8% from FY 2023). Net loss: CN¥680.7m (loss narrowed 27% from FY 2023). Revenue missed analyst estimates by 28%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance. Announcement • Mar 28
Yangmei Chemical Co.,Ltd to Report Q1, 2025 Results on Apr 30, 2025 Yangmei Chemical Co.,Ltd announced that they will report Q1, 2025 results on Apr 30, 2025 Announcement • Dec 27
Yangmei Chemical Co.,Ltd to Report Fiscal Year 2024 Results on Apr 19, 2025 Yangmei Chemical Co.,Ltd announced that they will report fiscal year 2024 results on Apr 19, 2025 Buy Or Sell Opportunity • Dec 12
Now 22% undervalued Over the last 90 days, the stock has risen 69% to CN¥2.82. The fair value is estimated to be CN¥3.60, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Oct 31
Third quarter 2024 earnings released: CN¥0.042 loss per share (vs CN¥0.006 loss in 3Q 2023) Third quarter 2024 results: CN¥0.042 loss per share (further deteriorated from CN¥0.006 loss in 3Q 2023). Revenue: CN¥2.76b (down 27% from 3Q 2023). Net loss: CN¥100.6m (loss widened CN¥85.8m from 3Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 107 percentage points per year, which is a significant difference in performance. Announcement • Sep 30
Yangmei Chemical Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024 Yangmei Chemical Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024 New Risk • Sep 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 30
Second quarter 2024 earnings released: CN¥0.10 loss per share (vs CN¥0.098 loss in 2Q 2023) Second quarter 2024 results: CN¥0.10 loss per share (further deteriorated from CN¥0.098 loss in 2Q 2023). Revenue: CN¥2.41b (down 28% from 2Q 2023). Net loss: CN¥249.0m (loss widened 7.5% from 2Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. Announcement • Jun 28
Yangmei Chemical Co.,Ltd to Report First Half, 2024 Results on Aug 30, 2024 Yangmei Chemical Co.,Ltd announced that they will report first half, 2024 results on Aug 30, 2024 Announcement • Jun 02
Yangmei Chemical Co.,Ltd, Annual General Meeting, Jun 21, 2024 Yangmei Chemical Co.,Ltd, Annual General Meeting, Jun 21, 2024, at 09:30 China Standard Time. Location: No. 72, Shuangta West Street, Yingze District, Taiyuan, Shanxi China Reported Earnings • Apr 24
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: CN¥0.57 loss per share (down from CN¥0.029 profit in FY 2022). Revenue: CN¥13.6b (down 20% from FY 2022). Net loss: CN¥1.37b (down CN¥1.44b from profit in FY 2022). Revenue missed analyst estimates by 29%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. Announcement • Mar 29
Yangmei Chemical Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024 Yangmei Chemical Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024 Board Change • Feb 22
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Duan Sheng Li was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Dec 30
Yangmei Chemical Co.,Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024 Yangmei Chemical Co.,Ltd announced that they will report fiscal year 2023 results on Apr 30, 2024 Reported Earnings • Oct 29
Third quarter 2023 earnings released: CN¥0.006 loss per share (vs CN¥0.015 loss in 3Q 2022) Third quarter 2023 results: CN¥0.006 loss per share (improved from CN¥0.015 loss in 3Q 2022). Revenue: CN¥3.76b (down 4.5% from 3Q 2022). Net loss: CN¥14.9m (loss narrowed 59% from 3Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings. Reported Earnings • Aug 31
Second quarter 2023 earnings released: CN¥0.098 loss per share (vs CN¥0.057 profit in 2Q 2022) Second quarter 2023 results: CN¥0.098 loss per share (down from CN¥0.057 profit in 2Q 2022). Revenue: CN¥3.32b (down 31% from 2Q 2022). Net loss: CN¥231.6m (down 271% from profit in 2Q 2022). Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Announcement • Jun 28
Yangmei Chemical Co.,Ltd to Report First Half, 2023 Results on Aug 30, 2023 Yangmei Chemical Co.,Ltd announced that they will report first half, 2023 results on Aug 30, 2023 Reported Earnings • Apr 15
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥0.029 (down from CN¥0.18 in FY 2021). Revenue: CN¥17.0b (down 9.1% from FY 2021). Net income: CN¥70.0m (down 84% from FY 2021). Profit margin: 0.4% (down from 2.3% in FY 2021). Revenue missed analyst estimates by 18%. Earnings per share (EPS) also missed analyst estimates by 67%. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Director Duan Sheng Li was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 29
Third quarter 2022 earnings released: CN¥0.015 loss per share (vs CN¥0.044 profit in 3Q 2021) Third quarter 2022 results: CN¥0.015 loss per share (down from CN¥0.044 profit in 3Q 2021). Revenue: CN¥3.94b (down 4.2% from 3Q 2021). Net loss: CN¥36.4m (down 135% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 27
Second quarter 2022 earnings released: EPS: CN¥0.057 (vs CN¥0.085 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.057 (down from CN¥0.085 in 2Q 2021). Revenue: CN¥4.82b (down 4.3% from 2Q 2021). Net income: CN¥135.4m (down 33% from 2Q 2021). Profit margin: 2.8% (down from 4.0% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 16%, compared to a 39% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 29
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2022 results: EPS: CN¥0.039 (down from CN¥0.056 in 1Q 2021). Revenue: CN¥4.73b (up 7.4% from 1Q 2021). Net income: CN¥92.6m (down 30% from 1Q 2021). Profit margin: 2.0% (down from 3.0% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 11%. Earnings per share (EPS) missed analyst estimates by 13%. Over the next year, revenue is forecast to grow 12%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 17
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: CN¥0.18 (up from CN¥0.054 in FY 2020). Revenue: CN¥18.7b (up 4.4% from FY 2020). Net income: CN¥431.7m (up 235% from FY 2020). Profit margin: 2.3% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 11%. Earnings per share (EPS) missed analyst estimates by 13%. Over the next year, revenue is expected to shrink by 13% compared to a 50% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥4.84, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 61% over the past three years. Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥5.83, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 133% over the past three years. Valuation Update With 7 Day Price Move • Nov 19
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥4.75, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Valuation Update With 7 Day Price Move • Nov 05
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥4.01, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 49% over the past three years. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.044 (vs CN¥0.036 loss in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: CN¥4.11b (down 14% from 3Q 2020). Net income: CN¥103.4m (up CN¥187.9m from 3Q 2020). Profit margin: 2.5% (up from net loss in 3Q 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥5.10, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 106% over the past three years. Valuation Update With 7 Day Price Move • Sep 23
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥7.90, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 204% over the past three years. Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥5.29, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 107% over the past three years. Reported Earnings • Aug 25
Second quarter 2021 earnings released: EPS CN¥0.085 (vs CN¥0.15 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥5.04b (up 16% from 2Q 2020). Net income: CN¥202.5m (up CN¥557.8m from 2Q 2020). Profit margin: 4.0% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥4.05, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 48% over the past three years. Reported Earnings • Apr 18
Full year 2020 earnings released: EPS CN¥0.054 (vs CN¥0.22 loss in FY 2019) The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: CN¥18.0b (flat on FY 2019). Net income: CN¥128.9m (up CN¥653.1m from FY 2019). Profit margin: 0.7% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Feb 22
New 90-day high: CN¥2.82 The company is up 21% from its price of CN¥2.33 on 24 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Jan 19
New 90-day high: CN¥2.75 The company is up 38% from its price of CN¥1.99 on 21 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. Is New 90 Day High Low • Dec 23
New 90-day high: CN¥2.50 The company is up 21% from its price of CN¥2.06 on 24 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Nov 20
New 90-day high: CN¥2.36 The company is up 1.0% from its price of CN¥2.34 on 21 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 6.0% over the same period. Reported Earnings • Nov 03
Third quarter 2020 earnings released: CN¥0.036 loss per share The company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: CN¥4.81b (up 1.9% from 3Q 2019). Net loss: CN¥84.5m (loss narrowed 57% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 111% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Announcement • Oct 27
Yangmei Chemical Co.,Ltd to Report Q3, 2020 Results on Oct 30, 2020 Yangmei Chemical Co.,Ltd announced that they will report Q3, 2020 results on Oct 30, 2020 Is New 90 Day High Low • Oct 22
New 90-day low: CN¥1.96 The company is down 4.0% from its price of CN¥2.05 on 24 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. Announcement • Jul 09
Yangmei Chemical Co.,Ltd to Report First Half, 2020 Results on Aug 26, 2020 Yangmei Chemical Co.,Ltd announced that they will report first half, 2020 results on Aug 26, 2020